[fcb5af]: / literature / by_gene / TAP1.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 32964767 10.1080/10428194.2020.1821011 2021 Frequent mutations in HLA and related genes in extranodal NK/T cell lymphomas. TAP1
2 35845006 10.1002/jha2.116 2020 Genetic aberrations of <i>NLRC5</i> are associated with downregulated MHC-I antigen presentation and impaired T-cell immunity in follicular lymphoma. TAP1
3 29107940 10.1038/nature24627 2017 Structure of the human MHC-I peptide-loading complex. TAP1
4 26910071 10.1007/978-1-4939-3347-1_7 2016 Fluorimetric Methods for Analysis of Permeability, Drug Transport Kinetics, and Inhibition of the ABCB1 Membrane Transporter. TAP1
5 23302045 10.3109/10428194.2013.764417 2013 Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis. TAP1
6 22419807 10.1128/JVI.07216-11 2012 Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA. TAP1
7 20020123 10.1007/s00262-009-0805-5 2010 Effective adoptive therapy of tap-deficient lymphoma using diverse high avidity alloreactive T cells. TAP1
8 17285277 10.1007/s00277-007-0256-z 2007 Upregulation of antigen-processing machinery components at mRNA level in acute lymphoblastic leukemia cells after CD40 stimulation. TAP1
9 16585582 10.4049/jimmunol.176.8.4869 2006 Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines. TAP1
10 15905524 10.4049/jimmunol.174.11.6829 2005 Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection. TAP1
11 16103103 10.1158/0008-5472.CAN-03-3734 2005 Identification of mechanisms underlying transporter associated with antigen processing deficiency in metastatic murine carcinomas. TAP1
12 15265880 10.4049/jimmunol.173.3.1526 2004 Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells. TAP1
13 14558951 2003 [Expression of transporter associated with antigen processing (TAP) in childhood acute leukemia and its clinical significance]. TAP1
14 11781255 10.1182/blood.v99.2.690 2002 HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease. TAP1
15 11169961 10.1002/1097-0215(200002)9999:9999&lt;::aid-ijc1056&gt;3.0.co;2-k 2001 Systemic deficits in transporter for antigen presentation (TAP)-1 or proteasome subunit LMP2 have little or no effect on tumor incidence. TAP1
16 11340574 10.1002/1097-0215(20010601)92:5&lt;692::aid-ijc1237&gt;3.0.co;2-z 2001 Expression of HLA class I, beta(2)-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK/T-cell lymphoma: Implications for tumor immune escape mechanism. TAP1
17 10760797 10.1002/(SICI)1521-4141(200004)30:4&lt;1088::AID-IMMU1088&gt;3.0.CO;2-O 2000 Innate and adaptive immunity to tumors: IL-12 is required for optimal responses. TAP1
18 10597194 10.1002/(sici)1097-0215(19991210)83:6&lt;772::aid-ijc13&gt;3.0.co;2-g 1999 CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines. TAP1
19 9443401 1998 Mouse models for hereditary nonpolyposis colorectal cancer. TAP1
20 9443410 1998 Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells. TAP1
21 9531330 10.1046/j.1365-2141.1998.00631.x 1998 Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course. TAP1
22 9551890 1998 Rejection of allogeneic and syngeneic but not MHC class I-deficient tumor grafts by MHC class I-deficient mice. TAP1
23 9562372 10.1016/s0165-2478(97)00157-0 1998 Peptide transport in human lymphoblastoid and tumor cells: effect of transporter associated with antigen presentation (TAP) polymorphism. TAP1
24 9680372 1998 Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognition. TAP1
25 9725200 1998 Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1. TAP1
26 9746788 1998 Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease. TAP1
27 9764810 10.1097/00008390-199808000-00008 1998 TAP prefers to transport melanoma antigenic peptides which are longer than the optimal T-cell epitope: evidence for further processing in the endoplasmic reticulum. TAP1
28 9129970 10.1016/S0198-8859(97)00001-3 1997 Localization of class I histocompatibility molecule assembly by subfractionation of the early secretory pathway. TAP1
29 9278330 1997 Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination. TAP1
30 9317117 1997 Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10. TAP1
31 9550373 1997 Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt's lymphoma cells. TAP1
32 8764046 10.1128/JVI.70.8.5357-5362.1996 1996 Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies. TAP1
33 8765034 10.1002/eji.1830260831 1996 Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2. TAP1
34 8900437 10.1002/(SICI)1097-0215(19961009)68:2&lt;251::AID-IJC19&gt;3.0.CO;2-D 1996 Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells. TAP1
35 7565411 10.1128/mr.59.3.387-405.1995 1995 Immune regulation in Epstein-Barr virus-associated diseases. TAP1
36 7774641 10.1002/eji.1830250536 1995 Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. TAP1
37 7517178 10.1093/intimm/6.4.639 1994 Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line. TAP1
38 7796675 10.1002/9780470514672.ch2 1994 Potential antigenic targets on Epstein-Barr virus-associated tumours and the host response. TAP1
39 7972022 10.1073/pnas.91.23.11128 1994 Abnormal class I assembly and peptide presentation in the nonobese diabetic mouse. TAP1